Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 45 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 27 | 2,361−7.9%/yr | −7.9%/yr | 6.11.0× | 73% | 2,320 in 2030−0.3%/yr |
| Dialysis access | 17 | 1,861−18%/yr | −18%/yr | 5.10.9× | 36% | 1,780 in 2030−0.7%/yr |
| Superficial venous ablation | 14 | 1,432−1.3%/yr | −1.3%/yr | 3.70.6× | 88% | 1,870 in 2030+4.6%/yr |
| Thrombectomy, IVC filters & venous stents | 6 | 554+0.1%/yr | +0.1%/yr | 1.50.9× | 4% | 570 in 2030+0.6%/yr |
| Carotid revascularization | 11 | 448−8.8%/yr | −8.8%/yr | 1.20.9× | 0% | 340 in 2030−4.7%/yr |
| Aortic endografts (EVAR/TEVAR) | 2 | 121−7.9%/yr | −7.9%/yr | 0.30.7× | 0% | 130 in 2030+1.1%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.